Drug details
Cerianna (fluoroestradiol f 18 injection)
type of Diagnostic Imaging Agents
Cerianna (fluoroestradiol F 18) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.
This drug may have the following side effects:
- changes in taste
- injection-site pain and
The following drugs are related to Cerianna, either as a replacement or used together:
- Xenoview (xenon xe 129 gas blend)